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Background: Valproic acid (VPA), one of the most important antiepileptic drugs, 
proved to be inevitable for epileptic pregnant women to limit the hazards of 
convulsions on the foetuses and mothers. Periconceptional folic acid supple-
mentation was investigated to protect against several birth defects. However, its 
role against VPA cerebellar toxicity was not properly investigated. The present 
study was conducted to evaluate the protective effect of folic acid against VPA 
cerebellar neurotoxicity.
Materials and methods: Twenty-four pregnant female albino rats were divided 
into three groups; group I (control group, did not receive any drugs), group II 
(given VPA at a dose of 50 mg/kg body weight once daily) and group III (given the 
same dose of VPA and 400 µg/kg of body weight folic acid once daily). Ten male 
offspring from each group were sacrificed at two ages: at 2 and 12 weeks after 
birth. Samples of cerebellar cortex were taken and prepared for light, electron 
microscopic examination, glial fibrillary acidic protein (GFAP) immunohistochemical 
study and histomorphometric analysis.  
Results: The present study confirmed the neurotoxic effect of prenatal VPA on the 
cerebellar cortex, especially on Purkinje cells. The cells appeared shrunken, reduced 
in density, disorganised and surrounded by empty haloes. Nuclear damage and 
axon degeneration in the form of vacuolation, loss of organelles and absence of 
neurofilaments with myelin sheath depletion were detected. Concomitant supply 
of folic acid was shown to retain the normal architecture of Purkinje cells with their 
axons and nuclei. In many animals receiving folic acid, the thickness of all layers 
of the cortex increased up to that of the control groups, after being markedly 
reduced in VPA-treated groups. GFAP immunoreaction was also improved against 
the strong positive gliosis detected in VPA-treated groups.  
Conclusions: The present study confirmed the protective role of folic acid against 
the cerebellar neurotoxic effects of VPA prenatal exposure. It is recommended 
that folic acid supplements should be given to every epileptic pregnant mother 
treated with VPA. (Folia Morphol 2018; 77, 2: 201–209)
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INTRODUCTION
Valproic acid (VPA) is a branched-chain carboxylic 
acid. It is the most widely used antiepileptic drug due 
to its great influence on a broad range of seizure types 
[6]. VPA proved to be unavoidable and could not be 
excluded in epileptic pregnant women [24]. Noncon-
trolled epileptic attacks during pregnancy produce 
high risk of injury to both mother and foetus [15]. 
However, VPA has been shown to cross the placenta 
and accumulate in the foetal circulation with higher 
concentration than that in the maternal blood, caus-
ing toxicity and teratogenicity [25]. 
Several studies detected that prenatal VPA expo-
sure induced marked degeneration of the cerebellar 
Purkinje and granular cells [17, 21–23]. A reduction 
of the size of the cerebellar hemisphere and Purkinje 
cell number were found after VPA injection on day 
12 of gestation in rats [10]. However, few studies 
investigated the effects of VPA on gliogenesis in the 
developing brain. They found alteration in the postna-
tal density of microglia and astrocytes after prenatal 
VPA administration [14, 16]. 
It was demonstrated that VPA initiated proteins 
and genes toxicity that have important roles in direct-
ing differentiation and growth during organogenesis 
with the production of multiple apoptotic cascades 
[9]. Foetal malformation and cellular damage induced 
by VPA were reported to be caused by increasing the 
total body free radicals [19]. Vitamin B9 (folate) was 
found to be an essential co-factor in the regulation of 
gene expression and new protein production which is 
vital for foetal cell differentiation, development and 
growth [13]. However, the study of the protective 
role of folic acid in prenatal VPA cerebellar toxicity 
was not properly investigated. Therefore, the aim 
of the present study was to examine the possible 
protective effects of folic acid on the histological and 
ultrastructural postnatal changes in the development 
of cerebellar cortex after prenatal VPA administration. 
MATERIALS AND METHODS
Chemicals
Valproic acid. Supplied as a syrup form of VPA (as 
sodium salt) 250 mg/5 mL; oral solution, a product 
of Sanofi Company, Egypt.  
Folic acid. Supplied as tablets (5 mg) a product of 
El-Nile Company for pharmaceutical and chemicals, 
Egypt. Each tablet was dispersed in 10 mL of distilled 
water. Each mL of the produced suspension contains 
500 µg of folic acid. Prior to administration of the 
required dose, the drug suspension was vortexed to 
ensure homogenous dispersion of the drug. 
Animals
A total of 24 adult female Sprague Dawley albino 
rats weighting 200–250 g each and 4–5 months old 
were used in the current study. Other 6 adult male 
albino rats were used for breeding. The rats were lo-
cally bred at the animal house at Faculty of Medicine, 
Cairo University, Egypt. They were housed at room 
temperature, had access to food and water ad libitum. 
The animals were given 2 weeks acclimatisation period 
before starting the experiment. They were treated in 
accordance with the international guidelines for the 
care and use of laboratory animals and the experiment 
protocol was approved by the Ethics Committee, Fac-
ulty of Medicine, Cairo University, Egypt. 
Experimental design
Female and male rats were housed separately 
(4 females and 1 male). Fertilisation was confirmed 
by vaginal smear examination every morning. The 
presence of vaginal plug was designed as day zero 
of gestation. Female rats with successful breeding 
were caged separately. The pregnant rats were equally 
divided into three groups (8 rats in each group) as 
follows: 
 — Group I (control group) — the rats of this group 
received no medications.  
 — Group II (VPA-treated group) — received VPA at 
a dose of 50 mg/kg body weight once daily by 
gastric gavage from day one of pregnancy; which 
is the therapeutic dose of VPA used in the treat-
ment of epilepsy and seizures [18]. 
 — Group III (VPA- and folic acid-treated group) — 
received VPA at a dose of 50 mg/kg body weight 
concomitantly with folic acid at a dose of 400 µg/ 
/kg body weight by gastric gavage once daily from 
day one of pregnancy; which is the protective dose 
given during pregnancy [28].
Ten male offspring from each group were sac-
rificed at two ages: at 2 and 12 weeks after birth 
(twenty rats from each group), forming the following 
subgroups for each group: 
 — Subgroup A — 2-week-old offspring.
 — Subgroup B — 12-week-old offspring.
The skull of each rat was opened by a circular 
incision from all-around. The skull cap was removed 
and the cerebrum was elevated and retracted by 
blunting methods. The dural folds were cut, then the 
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cerebellum was removed cautiously and prepared for 
the following studies. 
Light microscopic study
Two cubic mm, cut from different areas of the cer-
ebellar surface which represent the cerebellar cortex 
of the offspring, were immediately removed and fixed 
in Bouin solution, dehydrated in ascending series of 
ethanol, cleared in methyl benzoate and embedded 
in paraffin wax. Paraffin sections of 5–6 microns were 
prepared and stained with haematoxylin and eosin 
(H&E) stain [8] for routine histological examination.
Immunostaining of GFAP
Paraffin sections were deparaffinised on 
charged slides for localisation of glial fibrillary 
acidic protein (GFAP) using avidin-biotin complex 
(ABC). Nonspecific endogenous peroxidase activity 
was blocked by treatment with 0.9% hydrogen per-
oxide in absolute methanol for 10 min then incu-
bated with the primary anti-GFAP antibody at 1:100 
dilutions for 20 min at room temperature. Mouse 
monoclonal antibody (Glial Fibrillary Acidic Protein) 
Ab-1 (Clone GA-5) was used, which is specific to as-
trocytes and obtained from Lab Vision Corporation, 
Medico Co., Egypt (Cat. #MS-280-B0). The slides 
were washed with phosphate buffer then incubated 
with the secondary anti-mouse antibodies universal 
kits obtained from Zymed Corporation. Incubation 
with substrate chromogen 3,3’-diaminobenzidine 
(DAB) for 5–10 min was done, which resulted in 
brown-coloured precipitate at the antigen sites and 
Mayer’s haematoxylin was used as a counter stain. 
Positive control (brown discoloration of the glial cells 
mainly astrocytes denoting increase gliosis) was IMR5 
cells in brain, and for negative controls, incubation 
was carried out with the omission of the primary 
antiserum [3].
Electron microscopic examination 
Specimens from the cerebella were cut into small 
slices, fixed in 4% glutaraldehyde then washed in 
phosphate buffer and post-fixed in 1% osmium 
tetraoxide. Fixation was followed by dehydration and 
embedding in epoxy resins. Semithin sections (1 µm) 
were stained with toludine blue. Ultrathin sections 
(50–60 nm) were stained with uranyl acetate and 
lead citrate [8]. These sections were examined and 
photographed using a Joel, 100 CX II transmission 
electron microscope.
Histomorphometric measurements
The following parameters were measured in dif-
ferent fields with fixed field area 4 × 104 µm2:
 — thickness of the molecular and granular cortical 
layers of the cerebellum (×100 magnification);
 — Purkinje cells density counted in the high power 
field (×400);
 — the area per cent of GFAP immune reaction in the 
cerebellar cortex in the high power field (×400). 
The measurements were taken by an independ-
ent observer, who was unaware of the experimental 
design. They were obtained in ten non-overlapping 
fields per specimen at a magnification of 400 by us-
ing Leica LAS, V3.8 image analyser computer system 
(Switzerland).
Statistical analysis
The data obtained from all groups were expressed 
as mean and standard deviation (± SD) and subjected 
to statistical analysis using SPSS 22 software. One-
way analysis of variance (ANOVA) for comparison 
between the different groups was done. Compari-
son of significance between the control and various 
groups was made. P-values ≤ 0.05 were considered 
significant and p-values ≤ 0.001 were considered 
highly significant.  
RESULTS
Light microscopic examination 
Histological examination, with H&E stain, of the 
specimens of the offspring of the control group aged 
2 and 12 weeks (groups IA and IB), presented the nor-
mal architecture of the cerebellar cortex. The speci-
mens showed the molecular layer which appeared as 
a clear zone containing few basket cells. The Purkinje 
cell layer consisted of one row of flask-shaped cells 
with large, rounded and vesicular nuclei in pale cy-
toplasm. The internal granular layer contained small, 
deeply stained granular cells. The external granular 
layer was found in specimens of the offspring at the 
age of 2 weeks consisting of small closely packed 
cells with deeply stained rounded nuclei (Fig. 1A, B). 
The specimens of the rats treated with VPA (groups 
IIA and IIB) showed degenerative changes of the cer-
ebellar cortex presented with deeply stained pyknotic 
cells in the external granular layer. The molecular layer 
contained deeply stained pyknotic scattered basket 
cells and vacuolations. The Purkinje cells showed 
marked depletion, and appeared disfigured, shrunk-
en, and surrounded with vacuolated spaces. The in-
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ternal granular layer was densely packed with small 
pyknotic cells intervened with congested intercellular 
spaces. Marked haemorrhage was seen between the 
cerebellar folia (Fig. 1C, D). The specimens of the 
experimental group treated with VPA and folic acid 
(groups IIIA and IIIB) showed improvement of the 
cerebellar architecture. The molecular layer contained 
scattered basket cells with minimal areas of vacuola-
tion. The Purkinje cells appeared normal with oval 
shaped cells, vesicular nuclei and granular cytoplasm. 
The internal granular layer contained normal granular 
cells. The external granular layer in the 2-week-old rats 
was formed of many layers of darkly stained small 
granular cells (Fig. 1E, F). 
Immunohistochemistry of GFAP
Weak immune-expression of GFAP appeared in all 
layers of the cerebellar cortex in the form of brown 
areas in the control groups (IA and IB) (Fig. 2A, B). 
Strong positive immune-expression of GFAP; denot-
ing marked gliosis and proliferation of astrocytes, in 
the cerebellar cortex of the groups treated with VPA 
(groups IIA and IIB) (Fig. 2C, D). Mild positive immune-
expression of GFAP in the different layers of the cer-
ebellar cortex was found in the rats treated with VPA 
and folic acid (groups IIIA and IIIB) (Fig. 2E, F).
Electron microscopic examination
Specimens taken from the control group at the 
second and twelfth weeks (groups IA and IB) showed 
intact Purkinje cells, with well-defined cell membrane. 
Normal nuclei with regular intact nuclear envelope, 
finely dispersed chromatin and prominent nucleoli 
were found. The cytoplasm showed large num-
ber of mitochondria. Large number of myelinated 
and unmyelinated axons were found. Granule cells 
appeared with normal euchromatic rounded nuclei 
(Fig. 3A, B). The cerebellar cortex of the rats treated with 
VPA at the second week (group IIA) showed marked 
degeneration in the form of shrunken Purkinje cells, 
with irregular cell membrane. The nuclei appeared 
shrunken with irregular nuclear envelope, small nu-
cleoli and rarefied chromatin. The cytoplasm showed 
dilated rough endoplasmic reticulum and many cyto-
plasmic vacuolations. Degenerated mitochondria and 
axons were found completely vacuolated (Fig. 3C). 
A large number of degenerated swollen vacu-
olated axons, devoid of neurofilaments and other 
Figure 1. The cerebellar cortex: A. Group IA;  
B. Group IB. The molecular layer (ML) appears as 
a clear zone containing few basket cells (red ar-
rows). The Purkinje cell layer (P) consists of one 
row of flask-shaped cells with large, rounded and 
vesicular nuclei in pale cytoplasm (black arrow 
heads). The internal granular layer (IG) contains 
small, deeply stained granular cells (long black 
arrows). Note the covering pia mater (short black 
arrow) and the external granular layer (EG), con-
sisting of small closely packed cells with deeply 
stained rounded nuclei, in group IA. C. Group IIA; 
D. Group IIB. Deeply stained pyknotic cells in the 
external granular layer (EG). The molecular layer 
(ML) contains deeply stained pyknotic scattered 
basket cells and vacuolations. The Purkinje cells 
show marked depletion (short arrows), and appear 
disfigured, shrunken and surrounded with vacu-
olated spaces (yellow arrows). The internal granular 
layer (IG) is densely packed with small pyknotic 
cells (long arrows) with congested intercellular 
spaces. Note the haemorrhage (H) between the 
cerebellar folia. E. Group IIIA; F. Group IIIB. Improve-
ment of the cerebellar architecture. The molecular 
layer (ML) contains scattered basket cells with ar-
eas of vacuolation (short arrows). The Purkinje cells 
(long arrows) appear normal with oval shaped cells, 
vesicular nuclei and granular cytoplasm. The internal 
granular layer (IG) contains normal granular cells. 
The external granular layer (EG) is formed of many 
layers of darkly stained small granular cells in  
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Figure 2. The cerebellar cortex. A. Group IA;  
B. Group IB. Weak immune expression of glial  
fibrillary acidic protein (GFAP) in all layers of the 
cerebellar cortex (brown areas). C. Group IIA;  
D. Group IIB. Strong positive immune expression  
of GFAP in the cerebellar cortex (brown areas).  
E. Group IIIA; F. Group IIIB. Mild positive immune 
expression of GFAP in the different layers of the  




Figure 3. Electron micrographs of the cerebellar 
cortex. A. Group IA; B. Group IB. Intact Purkinje 
cell (PK). The nucleus (N) is apparently normal.  
The cytoplasm shows large number of mitochondria 
(M). Axon hillock (AX) of the cell is apparently  
normal. C. Group IIA. Shrunken nucleus (N) of 
Purkinje cell with irregular nuclear envelope (ar-
rows). Dilated rough endoplasmic reticulum (RER) 
and many cytoplasmic vacuolations (V) were seen. 
There are many degenerated mitochondria (M). 
Degenerated and vacuolated axons (AX) are seen. 
D. Group IIA. Swollen degenerated axons (arrows). 
Many vacuolated axons are seen (V)  
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organelles were detected surrounding the Purkinje 
cells (Fig. 3D). The specimens of the same group at 
the twelfth week (group IIB) showed degenerated 
Purkinje cells with irregular cell membrane. The nu-
clei appeared swollen with shrunken nucleoli. The 
cytoplasm contained many swollen empty mitochon-
dria and showed cytoplasmic vacuoles and many 
lysosomes. Large number of degenerated axons, some 
of them are completely devoid of neurofilaments 
and organelles, and microglial cells with irregular 
nuclei and cytoplasmic fat vacuoles were found in 
the specimens (Fig. 4A, B). Normal Purkinje cells ap-
peared in the rats of the VPA and folic acid treated 
group at the second week (group IIIA). Their nuclei 
appeared vesicular with regular nuclear envelope 
and prominent nucleoli. The cytoplasm was found 
nearly normal containing many mitochondria and 
rough endoplasmic reticula. There were many granu-
lar cells with apparently intact cytoplasm and nuclei. 
Microglial cells were noticed with their characteristic 
nuclei and dense cytoplasm. Adjacent to Purkinje 
cells, many astrocytes were detected with rarefied 
cytoplasm and indistinct cell boundaries and some 
vacuolated axons were seen (Fig. 4C, D). Specimens of 
the rats of the same group at the twelfth week (group 
IIIB) showed apparently normal Purkinje cells with 
euchromatic nuclei, regular nuclear envelope, and 
finely dispersed chromatin. The cytoplasm appeared 
granular and rich in elongated mitochondria. Their 
axon hillock contained many mitochondria. Normal 
myelinated axons which retained their myelin sheath, 
their characteristic neurofilaments and mitochondria 
were detected (Fig. 5A, B).
Histomorphometric studies
High statistically significant reduction was de-
tected in the density of Purkinje cells in group II at 
the second and twelfth weeks in comparison with 
the other groups. On the other hand, increase of the 
mean values of Purkinje cell density in group IIIA and 
IIIB was reported (Table 1). 
Concerning the thickness of the cortical layers of 
the cerebellum; the external granular, the molecular 
and the internal granular layers, marked significant 
reduction was found in groups (groups IIA and IIB) 
compared with the other groups. Improvement of 
their thickness was detected in groups IIIA and IIIB 
(Table 2).
Figure 4. Electron micrographs of the cerebellar 
cortex. A. Group IIB. A degenerated Purkinje cell 
(PK) with an irregular cell membrane (arrows) and 
degenerated nucleus (N). Swollen empty mito-
chondria (M), vacuoles (V) and lysosomes (arrow 
heads) were seen. B. Group IIB. Large number of 
degenerated axons (AX). Microglial cell (MG) with 
an irregular nucleus is noticed. C. Group IIIA. An 
apparently normal Purkinje cell (PK) with normal 
mitochondria (M). There are many intact granular 
cells (GC). D. Group IIIA. Part of Purkinje cell (PK) 
with large number of mitochondria (M) and rough 
endoplasmic reticulum (RER). Adjacent to it there 
are many astrocytes (AS) and microglia cell (MG). 
Some vacuolated axons are seen (V)  
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Figure 5. Electron micrographs of the cerebellar cortex. A. Group IIIB. Apparently normal Purkinje cell (PK) with elongated mitochondria (M). 
The axon hillock (AH) contains many mitochondria. B. Group IIIB. Apparently normal myelinated axons (long arrows) which retain their myelin 
sheath, their characteristic neurofilaments (NF) and rich in mitochondria (arrow heads) (A. TEM × 4000; B. × 10000).
Table 1. Mean ± standard deviation of the neuronal density of the Purkinje cells in the cerebellar cortex in the different studied groups
Group I Group II Group III
A B A B A B
Purkinje cell density 45.15 ± 12.8 56.41 ± 26.4 24.32 ± 23.3* 18.25 ± 48.1* 38.46 ± 63.2 34.25 ± 36.7
*Highly significant
Table 2. Mean ± standard deviation of the thickness of the different layers of the cerebellar cortex in the different experimental groups
Group I Group II Group III
A B A B A B
EGL 216.58 ± 21.4  164.12 ± 63.8*   186.5 ± 36.5  
ML 450.81 ± 21.2 842.48± 24.1 314.81 ± 13.14* 512.4 ± 25.6* 412.81 ± 25.6 612.8 ± 22.4 
IGL 505.62 ± 22.3 972.41 ± 21.26 386.62 ± 21.6* 712.8 ± 54.61* 480.62 ± 24.8 784.4 ± 51.61
*Highly significant; EGL — external granular layer; ML — molecular layer; IGL — internal granular layer
Table 3. Mean ± standard deviation of the area percent of GFAP in the cerebellar cortex in the different experimental groups
Group I Group II Group III
A B A B A B
GFAP 0.15% ± 13.2 0.66% ± 16.2 4.5% ± 23.1** 8.25% ± 41.8** 2.52% ± 21.2* 4.12% ± 18.3*
*Significant; **Highly significant; GFAP — glial fibrillary acidic protein
A B
The mean area per cent of GFAP immune expres-
sion in the cerebellar cortex of the offspring of group 
IIA and IIB was increased with high significance com-
pared with the other groups. Meanwhile, significant 
increase in the area per cent of GFAP was detected 
in groups IIIA and IIIB compared with the control 
groups (Table 3).
DISCUSSION
The present study confirmed the toxicity of VPA 
on the postnatal morphology and function of the 
cerebellar cortex of the offspring after prenatal ex-
posure. VPA produced degenerative changes in all 
cerebellar layers mostly manifested on Purkinje cells. 
These results are consistent with many studies that 
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detected the toxic effects of VPA on neuronal develop-
ment [10, 21]. Significant reduction of Purkinje cell 
density with absence of their processes found in the 
current work could be attributed to cytoskeletal de-
pletion leading to cytoplasmic vacuolation and empty 
pericellular spaces. These findings are in agreement 
with a recent research which detected Purkinje cell 
atrophy proving that repeated VPA exposure disrupt 
the structure and function of the cerebellum [17]. In 
addition, axon degeneration, found in the present 
study was explained by damage of the vital DNA, 
lipids and protein macromolecules of the cells [22]. 
Another study claimed that the disarrangement of 
Purkinje cell layer, after VPA administration between 
the tenth and twelfth days of pregnancy, could be 
due to delayed migration of the cells leading to dis-
turbance of their normal linear organisation [20]. 
However, the mechanism of this neurotoxic effect is 
still unclear. On the other hand, Kazlauskas et al. [14] 
found that prenatal exposure of VPA did not affect 
postnatal development of Purkinje cells. 
Concerning the other layers of the cerebellar 
cortex in the present study, the molecular layer of 
the offspring born to VPA treated mothers featured 
prominent spongiosis in the form of multiple vacu-
olated areas and pyknotic nuclei of basket cells, 
while the granular layer showed pericellular un-
stained haloes and haemorrhage. Similar observa-
tion was mentioned by other studies who declared 
that VPA exacerbated the damage of granular cells 
with amalgamation and loss of most of the cortical 
architecture [11, 22]. 
The mechanism of neuronal degeneration could 
be explained by intercellular biochemical disorders 
such as inhibition of oxidative phosphorylation in 
Purkinje cell mitochondria, impairment secretory and 
detoxication processes, abnormal protein produc-
tion or disrupted morphological cell integrity [23]. 
Moreover, VPA cerebellar toxicity was associated by 
marked elevation in the foetal oxidative stress and 
increase free radicals [1, 4]. From these points of 
view, the present study examined the protective effect 
of folic acid against VPA toxicity. Prenatal folic acid 
deficiency produced gene expression disorders with 
increase foetal oxidative stress inducing impairment 
of protein synthesis [27]. The findings of the current 
work confirmed the neuroprotective effects of folic 
acid manifested by normal Purkinje cells, resembling 
those of the control groups that could be due to its 
antioxidant role. In addition, folic acid played an im-
portant role in elimination of reactive oxygen species 
by prevention of lipid peroxidation [12].  
Other important findings of the current work, 
were manifested by the proliferation of Bergmann’s 
astrocytes, oligodendrocytes and microglial cells in 
the cerebellar cortex after VPA prenatal exposure. As-
trocyte activation demonstrated by statistically strong 
positive GFAP immune reaction could be a compensa-
tory mechanism after VPA neurodegeneration. These 
neuroglial cells were transformed into potentially 
cytotoxic cells mediated by the release of toxic re-
active oxygen and nitrogen species in response to 
neurodegeneration [26]. Concomitant folic acid treat-
ment with VPA in the current work induced marked 
improvement in the GFAP immunohistochemical reac-
tion proving the protective effect of folic acid.
Statistically significant reduction in the thickness 
of all cortical layers of VPA prenatal treated offspring 
was in agreement with previous studies which ex-
plained the cause of these changes. VPA disrupted 
the cyclin-dependent kinase system which controls 
cellular apoptosis, division, differentiation and func-
tion [2, 5]. Therefore, the present study examined 
the role of folic acid as a co-factor in the control of 
gene expression and protein synthesis essential for 
foetal cell differentiation and development protecting 
the neuronal cells from VPA teratogenicity. Moreo-
ver, it was proved that folic acid inhibited neuronal 
apoptosis acting as a coenzyme in single carbon 
transfers essential for the amino acid and nucleic 
acid metabolism [7]. 
CONCLUSIONS
The present study demonstrated the protective role 
of folic acid against the neurotoxicity of prenatal expo-
sure of VPA affecting the cerebellar cortex. It is recom-
mended to give folic acid supplements to the pregnant 
mothers treated with VPA to guard against such toxicity.
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